12 Health Care Stocks Moving In Thursday's After-Market Session
GainersOntrak (NASDAQ:OTRK) shares increased by 18.7% to $0.45 during Thursday's after-market session. The company's market cap stands at $18.9 million. Ocuphire Pharma (NASDAQ:OCUP) stock rose 7.82%
BenzingaApr 11 16:31 ET
12 Health Care Stocks Moving In Wednesday's After-Market Session
GainersRallybio (NASDAQ:RLYB) shares rose 31.9% to $2.15 during Wednesday's after-market session. The company's market cap stands at $81.2 million. Vera Therapeutics (NASDAQ:VERA) shares increased by
BenzingaApr 10 16:31 ET
Biolase Is Maintained at Buy by Ascendiant Capital
Biolase Is Maintained at Buy by Ascendiant Capital
Dow JonesApr 1 05:50 ET
Express News | Ascendiant Capital Maintains Buy on Biolase, Lowers Price Target to $4
Moomoo 24/7Apr 1 05:40 ET
Biolase's Strong Q4 Performance and Positive 2024 Outlook Affirm Buy Rating
TipRanksMar 23 07:35 ET
Biolase Price Target Cut to $0.40/Share From $2.50 by Benchmark
Biolase Price Target Cut to $0.40/Share From $2.50 by Benchmark
Dow JonesMar 22 13:51 ET
Biolase Is Maintained at Speculative Buy by Benchmark
Biolase Is Maintained at Speculative Buy by Benchmark
Dow JonesMar 22 13:51 ET
Express News | Benchmark Maintains Speculative Buy on Biolase, Lowers Price Target to $0.4
Moomoo 24/7Mar 22 13:42 ET
Biolase Analyst Ratings
Date Upside/Downside Analyst Firm Price Target Change Rating Change Previous / Current Rating 03/22/2024 111.75% Benchmark $2.5 → $0.4 Maintains Speculative Buy 05/31/2023 111.75% Lake Street $1.5 → $
BenzingaMar 22 13:37 ET
Dow Dips 200 Points; Nike Shares Fall After Q3 Results
U.S. stocks traded lower midway through trading, with the Dow Jones index falling more than 200 points. The Dow traded down 0.54% to 39,565.50 while the NASDAQ rose 0.04% to 16,408.74. The S&P 500 als
BenzingaMar 22 12:18 ET
Why BIOLASE Shares Are Surging Friday
BIOLASE, Inc. (NASDAQ:BIOL) shares are surging after the company reported better-than-expected fourth-quarter FY23 EPS results.Revenue of $13.49 million missed the consensus of $13.55 million. Gross p
BenzingaMar 22 11:13 ET
US Stocks Edge Lower; FedEx Posts Upbeat Earnings
U.S. stocks traded slightly lower this morning. Following the market opening Friday, the Dow traded down 0.06% to 39,758.88 while the NASDAQ fell 0.10% to 16,385.60. The S&P 500 also fell, dropping, 0
BenzingaMar 22 09:45 ET
12 Health Care Stocks Moving In Friday's Pre-Market Session
GainersBiolase (NASDAQ:BIOL) shares moved upwards by 61.5% to $0.24 during Friday's pre-market session. The market value of their outstanding shares is at $4.6 million. The company's, Q4 earnings came
BenzingaMar 22 09:06 ET
US Stock Futures Flat Ahead of Powell Speech After Reaching Record Highs on Thursday
US stock futures were flat in Friday's premarket session after equity indexes closed at record highs on Thursday, as investors awaited Federal Reserve Chairman Jerome Powell's speech, scheduled for 9:
MT NewswiresMar 22 08:24 ET
Outlook OTLK Positive CHMP Opinion; BIOLASE BIOL Earnings
BioPharmCatalystMar 22 08:24 ET
Top Premarket Gainers
Biolase (BIOL) shares surged nearly 72% in recent Friday premarket activity, a day after it reported a narrower Q4 net loss per share from a year earlier. Nova LifeStyle (NVFY) shares jumped 76%, addi
MT NewswiresMar 22 07:58 ET
BIOLASE, Inc. (BIOL) Witnesses Remarkable Surge With Earnings Beat
BIOLASE, Inc. (NASDAQ: BIOL) saw a relatively subdued trading day on Thursday, with its shares ticking up by a marginal 0.60% from $0.1491 to $0.1500. However, the after-market scenario presented a starkly different narrative. Following the unveiling of its earnings report, BIOLASE experienced an astounding surge of 47%, propelling its stock price north of the ...
Stocks TelegraphMar 22 03:04 ET
Earnings Call Summary | Biolase(BIOL.US) Q4 2023 Earnings Conference
The following is a summary of the BIOLASE, Inc. (BIOL) Q4 2023 Earnings Call Transcript:Financial Performance:BIOLASE reported a modest increase in net revenue of $49.2 million for the full year compa
moomoo AIMar 21 19:31 ET · Conference Call
12 Health Care Stocks Moving In Thursday's After-Market Session
GainersBiolase (NASDAQ:BIOL) stock rose 20.0% to $0.18 during Thursday's after-market session. The market value of their outstanding shares is at $3.4 million. As per the press release, Q4 earnings ca
BenzingaMar 21 17:33 ET
Express News | Biolase Anticipates Q1 Net Revenue To Exceed $10M, Relatively Flat Y/Y (Est $10.796M); 2024 Net Revenue To Increase 6%-8% To $52M-$53M (Est $53.068M)
Moomoo 24/7Mar 21 16:55 ET
No Data
No Data